FormFactor, Inc. filings document a Nasdaq-listed semiconductor test and measurement company with common stock registered under the symbol FORM. Its Form 8-K reports furnish quarterly operating results and financial-condition updates, while other material-event filings cover restructuring actions tied to manufacturing consolidation, executive and director changes, and a revolving credit agreement for working capital and general corporate purposes.
The company’s proxy materials describe board elections, committee matters, executive compensation, equity awards, pay-versus-performance disclosure and other annual meeting governance subjects. Together, the filings provide formal disclosure on FormFactor’s capital structure, governance practices, operating performance and risk-related corporate actions.
Filer submitted a Form 144 notice to sell restricted common stock. The notice lists three tranches of Restricted Stock dated 08/02/2024, 08/07/2024, and 11/07/2024 for 2,632, 6,030, and 2,632 shares respectively. The filing shows sales reported in the past three months of 10,227 and 8,664 shares with dollar amounts.
FormFactor is asking stockholders to approve several items at its 2026 virtual annual meeting, including electing seven directors, updating its charter for Delaware officer exculpation, an advisory vote on 2025 executive pay, and expanding its 2012 Equity Incentive Plan by 5,000,000 shares.
The company highlights record 2025 revenue of $785 million, up 2.8% from 2024, supported by demand tied to generative AI, high‑bandwidth memory, and co‑packaged optics. Management reports non‑GAAP gross margin improvement through cycle‑time and yield gains, a 2026-focused restructuring, a new low‑cost Texas manufacturing facility, and the Keystone Photonics acquisition to strengthen optical test capabilities.
The Board emphasizes its declassified, majority‑independent structure, annual CEO evaluation, active risk oversight, and stock ownership guidelines. Directors are compensated with cash retainers and time‑vested RSUs, and the Board recommends voting in favor of all five proposals at the May 15, 2026 meeting.
FormFactor Inc: Amendment to a Schedule 13G/A shows The Vanguard Group reports 0 shares beneficially owned of FormFactor Inc common stock and 0% of the class, reflecting an internal realignment effective January 12, 2026 per SEC Release No. 34-39538.
The filing lists Vanguard's address and states certain subsidiaries will report separately; the reporting person signed the amendment on 03/26/2026.
FormFactor, Inc. is soliciting proxies for its 2026 Annual Meeting of Stockholders to be held virtually on May 15, 2026. The Proxy Statement reviews 2025 performance, governance, board composition, and five shareholder proposals: election of seven directors; an amendment to the Certificate of Incorporation to add officer exculpation; advisory approval of 2025 executive compensation; an increase of 5,000,000 shares to the 2012 Equity Incentive Plan; and ratification of KPMG as independent auditors. The Statement highlights $785 million revenue in 2025, margin-improvement initiatives, a January 2026 restructuring, the Farmers Branch, Texas facility purchase, and the acquisition of Keystone Photonics.
FORMFACTOR INC CEO Mike Slessor reported open-market sales of 10,227 shares of Common Stock. On March 18, 2026, he sold 1,900 shares at $94.10, 5,495 shares at $95.21, and 2,832 shares at $95.73. A footnote states the sales occurred automatically under a Rule 10b5-1 trading plan adopted on August 19, 2025. Following these transactions, he directly holds 460,859 shares.
Form 144 filing reporting sales of Common stock by Mike Slessor. The filing lists three dispositions: 01/06/2026 sale of 39,606 shares for $2,574,390.00, 01/15/2026 sale of 13,088 shares for $1,005,295.82, and 02/18/2026 sale of 8,664 shares for $815,576.98. The securities previously issued as restricted stock include grants dated 05/07/2024 (3,800 shares) and 08/01/2024 (6,427 shares).
FORMFACTOR INC Chief Financial Officer Aric Brendan McKinnis reported an open-market sale of 3,462 shares of common stock on March 5, 2026 at $90.42 per share. The transaction occurred automatically under a Rule 10b5-1 trading plan adopted on December 4, 2025, and left him with 11,140 shares of directly owned common stock.
Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 proposing the sale of common stock. The filing lists multiple restricted-stock grants and an Employee Stock Purchase Plan allocation with grant dates and the following quantities: 580, 391, 580, 359, 341, 535, 96, 580 linked to specific grant dates.
FormFactor Inc. CFO Aric Brendan McKinnis reported equity award activity involving restricted stock units and common shares. On March 2, 2026, 773 restricted stock units were converted into 773 shares of common stock at $0.00 per share as part of an RSU settlement.
On the same date, 193 common shares were disposed of at $99.70 per share to cover tax withholding obligations tied to the vesting of these RSUs. The RSUs were granted on June 2, 2023 and vest in twelve quarterly installments from September 2, 2023 through June 2, 2026, subject to continued employment and certain severance and change‑of‑control arrangements.